Skip to main content

DIAGNOSTICO Y SEGUIMIENTO PERSONALIZADO DE PACIENTES CON RIESGO DE PATOLOGIA DIGESTIVA TUMORAL MEDIANTE BIOPSIA LIQUIDA TERMICA (TLB) APLICANDO HERRAMIENTAS DE INTELIGENCIA ARTIFICIAL Y NANOTECNOLOGIA

PI21/00394

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2021
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE INVESTIGACION SANITARIA ARAGON
Execution centre INSTITUTO DE INVESTIGACION SANITARIA ARAGON

Resultados relacionados

Resultados totales (Incluyendo duplicados): 20
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Biological Calorimetry: Old Friend, New Insights

  • Abian, Olga
  • Vega, Sonia
  • Velázquez-Campoy, Adrián
Calorimetry is an old experimental technique (first instrument developed in S. XVIII), but it is broadly used and still provides key information for understanding biological processes at the molecular level, particularly, cooperative phenomena in protein interactions. Here, we review and highlight some key aspects of biological calorimetry. Several biological systems will be described in which calorimetry was instrumental for modeling the behavior of the protein and obtaining further biological insight., This work was supported by the Spanish Ministry of Economy and Competitiveness [BFU2016-78232-P to A.V.C.] and the Ministry of Science and Innovation MCIN/AEI/ 10.13039/501100011033/; “ERDF A way of Making Europe” [PID2021-127296OB-I00 to A.V.C.]; the Miguel Servet Program from Instituto de Salud Carlos III [CPII13/00017 to OA]; the Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III and the European Union (ERDF/ESF, “Investing in your future”) [PI18/00349 and PI21/00394 to O.A.]; the Diputación General de Aragón [Protein Targets and Bioactive Compounds Group E45_20R to A.V.C., and Digestive Pathology Group B25_20R to O.A.]; and the Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation

  • Peralta-Moreno, María Nuria
  • Mena, Yago
  • Ortega-Alarcón, David
  • Jiménez-Alesanco, Ana
  • Vega, Sonia
  • Abian, Olga
  • Velázquez-Campoy, Adrián
  • Thomson, Timothy M.
  • Pinto, Marta
  • Granadino-Roldán, José Manuel
  • Santos Tomás, María
  • Pérez, Juan J.
  • Rubio-Martínez, Jaime
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)., The development of specific antiviral therapies targeting SARS-CoV-2 remains fundamental because of the continued high incidence of COVID-19 and limited accessibility to antivirals in some countries. In this context, dark chemical matter (DCM), a set of drug-like compounds with outstanding selectivity profiles that have never shown bioactivity despite being extensively assayed, appears to be an excellent starting point for drug development. Accordingly, in this study, we performed a high-throughput screening to identify inhibitors of the SARS-CoV-2 main protease (Mpro) using DCM compounds as ligands. Multiple receptors and two different docking scoring functions were employed to identify the best molecular docking poses. The selected structures were subjected to extensive conventional and Gaussian accelerated molecular dynamics. From the results, four compounds with the best molecular behavior and binding energy were selected for experimental testing, one of which presented inhibitory activity with a Ki value of 48 ± 5 μM. Through virtual screening, we identified a significant starting point for drug development, shedding new light on DCM compounds., This research was funded by The Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya (2021SGR00350) and the Spanish Structures and Excellence María de Maeztu program, grant number CEX2021-001202-M; the Universitat de Barcelona PREDOCS-UB 2020 grant (5760700—Institut de Química Teòrica i Computacional to M.N.P.-M.); Fundación hna (to A.V.C. and O.A.); Fondo Investiga COVID-19 from Instituto de Investigación Sanitaria de Aragón IIS-A (to O.A. and A.V.-C.); the Spanish Ministry of Economy and Competitiveness (BFU2016-78232-P to A.V.C., FPI predoctoral contract BES-2017-080739 to D.O.A.); the Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033/ and “ERDF A way of Making Europe” (PID2021-127296OB-I00 to A.V.C.); the Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III and European Union (ERDF/ESF, “Investing in your future”) (PI18/00349 and PI21/00394 to O.A.); the Diputación General de Aragón (Protein Targets and Bioactive Compounds Group E45_23R to A.V.C., Digestive Pathology Group B25_23R to O.A., and predoctoral contract 2019 to A.J.A.); the Consejo Superior de Investigaciones Científicas (COV-006 and COV-201 to T.M.T.); the Plataforma Temática Interdisciplinar Salud Global (PTI-SG + SGL2103019 to T.M.T.); the Agència de Gestió d’Ajuts Universitaris i de Recerca (2020PANDE00048 to J.R.-M and T.M.T.); and the Plan Nacional de I + D (PID-107139RB-C21 to T.M.T.)., With funding from the Spanish government through the ‘María de Maeztu Unit of Excelence’ accreditation (CEX2021-001202-M)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Biological Calorimetry: Old Friend, New Insights

  • Abian, Olga
  • Vega, Sonia
  • Velazquez-Campoy, Adrian
Calorimetry is an old experimental technique (first instrument developed in S. XVIII), but it is broadly used and still provides key information for understanding biological processes at the molecular level, particularly, cooperative phenomena in protein interactions. Here, we review and highlight some key aspects of biological calorimetry. Several biological systems will be described in which calorimetry was instrumental for modeling the behavior of the protein and obtaining further biological insight.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Bowel preparation for colonoscopy changes serum composition as detected by thermal liquid biopsy and fluorescence spectroscopy

  • Hermoso-Durán, S.
  • Domper-Arnal, M. J.
  • Roncales, P.
  • Vega, S.
  • Sánchez-Gracia, Ó.
  • Ojeda, J. L.
  • Lanas, Á.
  • Velázquez-Campoy, A.
  • Abian, O.
(1) Background: About 50% of prescribed colonoscopies report no pathological findings. A secondary screening test after fecal immunochemical test positivity (FIT+) would be required. Considering thermal liquid biopsy (TLB) as a potential secondary test, the aim of this work was to study possible interferences of colonoscopy bowel preparation on TLB outcome on a retrospective study; (2) Methods: Three groups were studied: 1/514 FIT(+) patients enrolled in a colorectal screening program (CN and CP with normal and pathological colonoscopy, respectively), with blood samples obtained just before colonoscopy and after bowel preparation; 2/55 patients from the CN group with blood sample redrawn after only standard 8–10 h fasting and no bowel preparation (CNR); and 3/55 blood donors from the biobank considered as a healthy control group; (3) Results: The results showed that from the 514 patients undergoing colonoscopy, 247 had CN and 267 had CP. TLB parameters in these two groups were similar but different from those of the blood donors. The resampled patients (with normal colonoscopy and no bowel preparation) had similar TLB parameters to those of the blood donors. TLB parameters together with fluorescence spectra and other serum indicators (albumin and C-reactive protein) confirmed the statistically significant differences between normal colonoscopy patients with and without bowel preparation; (4) Conclusions: Bowel preparation seemed to alter serum protein levels and altered TLB parameters (different from a healthy subject). The diagnostic capability of other liquid-biopsy-based methods might also be compromised. Blood extraction after bowel preparation for colonoscopy should be avoided.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Autochthonous Peruvian natural plants as potential SARS-CoV-2 Mpro main protease inhibitors

  • Peralta-Moreno, M. N.
  • Antón-Muñoz, V.
  • Ortega-Alarcón, D.
  • Jiménez-Alesanco, A.
  • Vega, S.
  • Abian, O.
  • Velázquez-Campoy, A.
  • Thomson, T. M.
  • Granadino-Roldán, J. M.
  • Machicado, C.
  • Rubio-Martínez, J.
Over 750 million cases of COVID-19, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), have been reported since the onset of the global outbreak. The need for effective treatments has spurred intensive research for therapeutic agents based on pharmaceutical repositioning or natural products. In light of prior studies asserting the bioactivity of natural compounds of the autochthonous Peruvian flora, the present study focuses on the identification SARS-CoV-2 Mpro main protease dimer inhibitors. To this end, a target-based virtual screening was performed over a representative set of Peruvian flora-derived natural compounds. The best poses obtained from the ensemble molecular docking process were selected. These structures were subjected to extensive molecular dynamics steps for the computation of binding free energies along the trajectory and evaluation of the stability of the complexes. The compounds exhibiting the best free energy behaviors were selected for in vitro testing, confirming the inhibitory activity of Hyperoside against Mpro, with a Ki value lower than 20 µM, presumably through allosteric modulation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cells

  • Araujo-Abad, Salomé
  • Fuentes-Baile, María
  • Rizzuti, Bruno
  • Bazán, J. Fernando
  • Villamarin-Ortiz, Adrián
  • Saceda, Miguel
  • Fernández, Eduardo
  • Vidal, Miguel
  • Abian, Olga
  • Velázquez-Campoy, Adrián
  • Juan Romero, Camino de
  • Neira, José L.
RYBP (Ring1 and YY 1 binding protein) is a multifunctional, intrinsically disordered protein (IDP), best described as a transcriptional regulator. It exhibits a ubiquitin-binding functionality, binds to other transcription factors, and has a key role during embryonic development. RYBP, which folds upon binding to DNA, has a Zn-finger domain at its N-terminal region. By contrast, PADI4 is a well-folded protein and it is one the human isoforms of a family of enzymes implicated in the conversion of arginine to citrulline. As both proteins intervene in signaling pathways related to cancer development and are found in the same localizations within the cell, we hypothesized they may interact. We observed their association in the nucleus and cytosol in several cancer cell lines, by using immunofluorescence (IF) and proximity ligation assays (PLAs). Binding also occurred in vitro, as measured by isothermal titration calorimetry (ITC) and fluorescence, with a low micromolar affinity (~1 μM). AlphaFold2-multimer (AF2) results indicate that PADI4's catalytic domain interacts with the Arg53 of RYBP docking into its active site. As RYBP sensitizes cells to PARP (Poly (ADP-ribose) polymerase) inhibitors, we applied them in combination with an enzymatic inhibitor of PADI4 observing a change in cell proliferation, and the hampering of the interaction of both proteins. This study unveils for the first time the possible citrullination of an IDP, and suggests that this new interaction, whether it involves or not citrullination of RYBP, might have implications in cancer development and progression.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Conformational Stability of the N-Terminal Region of MDM2

  • Rizzuti, Bruno
  • Abian, Olga
  • Velazquez-Campoy, Adrián
  • Neira, José L.
MDM2 is an E3 ubiquitin ligase which is crucial for the degradation and inhibition of the key tumor-suppressor protein p53. In this work, we explored the stability and the conformational features of the N-terminal region of MDM2 (N-MDM2), through which it binds to the p53 protein as well as other protein partners. The isolated domain possessed a native-like conformational stability in a narrow pH range (7.0 to 10.0), as shown by intrinsic and 8-anilinonapthalene-1-sulfonic acid (ANS) fluorescence, far-UV circular dichroism (CD), and size exclusion chromatography (SEC). Guanidinium chloride (GdmCl) denaturation followed by intrinsic and ANS fluorescence, far-UV CD and SEC at physiological pH, and differential scanning calorimetry (DSC) and thermo-fluorescence experiments showed that (i) the conformational stability of isolated N-MDM2 was very low; and (ii) unfolding occurred through the presence of several intermediates. The presence of a hierarchy in the unfolding intermediates was also evidenced through DSC and by simulating the unfolding process with the help of computational techniques based on constraint network analysis (CNA). We propose that the low stability of this protein is related to its inherent flexibility and its ability to interact with several molecular partners through different routes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Extending MeCP2 interactome: canonical nucleosomal histones interact with MeCP2

  • Ortega-Alarcón, David
  • Claveria-Gimeno, Rafael
  • Vega, Sonia
  • Kalani, Ladan
  • Jorge-Torres, Olga C
  • Esteller, Manel
  • Ausio, Juan
  • Abian, Olga
  • Velázquez-Campoy, Adrián
MeCP2 is a general regulator of transcription involved in the repression/activation of genes depending on the local epigenetic context. It acts as a chromatin regulator and binds with exquisite specificity to gene promoters. The set of epigenetic marks recognized by MeCP2 has been already established (mainly, cytosine modifications in CpG and CpA), as well as many of the constituents of its interactome. We unveil a new set of interactions for MeCP2 with the four canonical nucleosomal histones. MeCP2 interacts with high affinity with H2A, H2B, H3 and H4. In addition, Rett syndrome associated mutations in MeCP2 and histone epigenetic marks modulate these interactions. Given the abundance and the structural/functional relevance of histones and their involvement in epigenetic regulation, this new set of interactions and its modulating elements provide a new addition to the ‘alphabet’ for this epigenetic reader.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Unveiling the Binding between the Armadillo-Repeat Domain of Plakophilin 1 and the Intrinsically Disordered Transcriptional Repressor RYBP

  • Araujo-Abad, Salome
  • Rizzuti, Bruno
  • Vidal, Miguel
  • Abian, Olga
  • Fárez-Vidal, María Esther
  • Velázquez-Campoy, Adrián
  • De Juan Romero, Camino
  • Neira, José L.
Plakophilin 1 (PKP1), a member of the p120ctn subfamily of the armadillo (ARM)-repeat-containing proteins, is an important structural component of cell–cell adhesion scaffolds although it can also be ubiquitously found in the cytoplasm and the nucleus. RYBP (RING 1A and YY1 binding protein) is a multifunctional intrinsically disordered protein (IDP) best described as a transcriptional regulator. Both proteins are involved in the development and metastasis of several types of tumors. We studied the binding of the armadillo domain of PKP1 (ARM-PKP1) with RYBP by using in cellulo methods, namely immunofluorescence (IF) and proximity ligation assay (PLA), and in vitro biophysical techniques, namely fluorescence, far-ultraviolet (far-UV) circular dichroism (CD), and isothermal titration calorimetry (ITC). We also characterized the binding of the two proteins by using in silico experiments. Our results showed that there was binding in tumor and non-tumoral cell lines. Binding in vitro between the two proteins was also monitored and found to occur with a dissociation constant in the low micromolar range (~10 μM). Finally, in silico experiments provided additional information on the possible structure of the binding complex, especially on the binding ARM-PKP1 hot-spot. Our findings suggest that RYBP might be a rescuer of the high expression of PKP1 in tumors, where it could decrease the epithelial–mesenchymal transition in some cancer cells.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation

  • Peralta-Moreno, M. N
  • Mena, Y.
  • Ortega-Alarcon, D.
  • Jiménez-Alesanco, A.
  • Vega, S.
  • Abian, O.
  • Velázquez-Campoy, A.
  • Thomson, T. M.
  • Pinto, M.
  • Granadino-Roldán, J. M.
  • Tomás, M.
  • Pérez, J. J.
  • Rubio-Martínez, J.
The development of specific antiviral therapies targeting SARS-CoV-2 remains fundamental because of the continued high incidence of COVID-19 and limited accessibility to antivirals in some countries. In this context, dark chemical matter (DCM), a set of drug-like compounds with outstanding selectivity profiles that have never shown bioactivity despite being extensively assayed, appears to be an excellent starting point for drug development. Accordingly, in this study, we performed a high-throughput screening to identify inhibitors of the SARS-CoV-2 main protease (Mpro) using DCM compounds as ligands. Multiple receptors and two different docking scoring functions were employed to identify the best molecular docking poses. The selected structures were subjected to extensive conventional and Gaussian accelerated molecular dynamics. From the results, four compounds with the best molecular behavior and binding energy were selected for experimental testing, one of which presented inhibitory activity with a Ki value of 48 ± 5 μM. Through virtual screening, we identified a significant starting point for drug development, shedding new light on DCM compounds
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Isolated auto-citrullinated regions of PADI4 associate to the intact protein without altering their disordered conformation

  • Neira, José L.
  • Rizzuti, Bruno
  • Abian, Olga
  • Velazquez-Campoy, Adrian
PADI4 is one of the human isoforms of a group of enzymes intervening in the conversion of arginine to citrulline. It is involved in the development of several types of tumors, as well as other immunological illnesses, such as psoriasis, multiple sclerosis, or rheumatoid arthritis. PADI4 auto-citrullinates in several regions of its sequence, namely in correspondence of residues Arg205, Arg212, Arg218, and Arg383. We wanted to study whether the citrullinated moiety affects the conformation of nearby regions and its binding to intact PADI4. We designed two series of synthetic peptides comprising either the wild-type or the relative citrullinated versions of such regions – i.e., a first series of peptides comprising the first three arginines, and a second series comprising Arg383. We studied their conformational properties in isolation by using fluorescence, far-ultraviolet (UV) circular dichroism (CD), and 2Dsingle bond1H NMR. Furthermore, we characterized the binding of the wild-type and citrullinated peptides in the two series to the intact PADI4, by using isothermal titration calorimetry (ITC), fluorescence, and biolayer interferometry (BLI), as well as by molecular docking simulations. We observed that citrullination did not alter the local conformational propensities of the isolated peptides. Nevertheless, for all the peptides in the two series, citrullination slowed down the kinetic koff rates of the binding reaction to PADI4, probably due to differences in electrostatic effects compared to the presence of arginine. The affinities of PADI4 for unmodified peptides were slightly larger than those of the corresponding citrullinated ones in the two series, but they were all within the same range, indicating that there were no relevant variations in the thermodynamics of binding due to sequence effects. These results highlight details of the self-citrullination of PADI4 and, more generally, of possible auto-catalytic mechanisms taking place in vivo for other citrullinating enzymes or, alternatively, in proteins undergoing citrullination passively.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Citrullinating enzyme PADI4 and transcriptional repressor RING1B bind in cancer cells

  • Araujo-Abad, Salome
  • Rizzuti, Bruno
  • Soto-Conde, Lourdes
  • Vidal, Miguel
  • Abian, Olga
  • Velazquez-Campoy, Adrian
  • Neira, José L.
  • de Juan Romero, Camino
Polycomb groups (PcGs) are transcriptional repressors, formed by a complex of several proteins, involved in multicellular development and cancer epigenetics. One of these proteins is the E3 ubiquitin-protein ligase RING1 (or RING1B), associated with the regulation of transcriptional repression and responsible for monoubiquitylation of the histone H2A. On the other hand, PADI4 is one of the human isoforms of a family of enzymes implicated in the conversion of arginine to citrulline, and it is also involved in the development of glioblastoma, among other types of cancers. In this work, we showed the association of PADI4 and RING1B in the nucleus and cytosol in several cancer cell lines by using immunofluorescence and proximity ligation assays. Furthermore, we demonstrated that binding was hampered in the presence of GSK484, an enzymatic PADI4 inhibitor, suggesting that RING1B could bind to the active site of PADI4, as confirmed by protein-protein docking simulations. In vitro and in silico findings showed that binding to PADI4 occurred for the isolated fragments corresponding to both the N-terminal (residues 1–221) and C-terminal (residues 228–336) regions of RING1B. Binding to PADI4 was also hampered by GSK484, as shown by isothermal titration calorimetry (ITC) experiments for the sole N-terminal region, and by both NMR and ITC for the C-terminal one. The dissociation constants between PADI4 and any of the two isolated RING1B fragments were in the low micromolar range (~2–10 μM), as measured by fluorescence and ITC. The interaction between RING1B and PADI4 might imply citrullination of the former, leading to several biological consequences, as well as being of potential therapeutic relevance for improving cancer treatment with the generation of new antigens.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Development of an efficient NUPR1 inhibitor with anticancer activity

  • Liu, Xi
  • Jimenez-Alesanco, Ana
  • Li, Zexian
  • Rizzuti, Bruno
  • Neira, José L.
  • Estaras, Matías
  • Peng, Ling
  • Chuluyan, Eduardo
  • Garona, Juan
  • Gottardo, Florencia
  • Velazquez-Campoy, Adrián
  • Xia, Yi
  • Abian, Olga
  • Santofimia-Castaño, Patricia
  • Iovanna, Juan
Pancreatic cancer is highly lethal and has limited treatment options available. Our team had previously developed ZZW-115, a promising drug candidate that targets the nuclear protein 1 (NUPR1), which is involved in pancreatic cancer development and progression. However, clinical translation of ZZW-115 was hindered due to potential cardiotoxicity caused by its interaction with the human Ether-à-go-go-Related Gene (hERG) potassium channel. To address this, we have performed a high-throughput screening of 10,000 compounds from the HitFinder Chemical Library, and identified AJO14 as a lead compound that binds to NUPR1, without having favorable affinity towards hERG. AJO14 induced cell death through apoptosis, necroptosis, and parthanatos (induced by the poly-ADP ribose polymerase (PARP) overactivation), driven by mitochondrial catastrophe and decreased ATP production. This process seemed to be mediated by the hyperPARylation (an excessive modification of proteins by PARP, leading to cellular dysfunction), as it could be reversed by Olaparib, a PARP inhibitor. In xenografted mice, AJO14 demonstrated a dose-dependent tumor reduction activity. Furthermore, we attempted to improve the anti-cancer properties of AJO14 by molecular modification of the lead compound. Among the 51 candidates obtained and tested, 8 compounds exhibited a significant increase in efficacy and have been retained for further studies, especially LZX-2-73. These AJO14-derived compounds offer potent NUPR1 inhibition for pancreatic cancer treatment, without cardiotoxicity concerns.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Thermal Liquid Biopsy: A Promising Tool for the Differential Diagnosis of Pancreatic Cystic Lesions and Malignancy Detection

  • Millastre, Judith
  • Hermoso-Durán, Sonia
  • Solórzano, María Ortiz de
  • Fraunhoffer, Nicolas
  • García-Rayado, Guillermo
  • Vega, Sonia
  • Bujanda, Luis
  • Sostres, Carlos
  • Lanas, Ángel
  • Velázquez-Campoy, Adrián
  • Abian, Olga
Background/Objectives: Mucinous epithelial pancreatic cystic lesions (PCLs) are premalignant lesions readily detectable through imaging techniques such as multidetector computed tomography, magnetic resonance imaging, and endoscopic ultrasound (EUS). However, distinguishing these from other PCLs with lower or no malignant potential, and the early identification of those undergoing malignant transformation, remains a diagnostic challenge. Current methods, including biochemical markers in intracystic fluid (ICF) and genomic studies, offer some assistance but are not always reliable or accessible. Thermal liquid biopsy (TLB) is a novel diagnostic tool that examines the thermal profile (thermogram) of biological samples, reflecting their response to heat and thereby revealing characteristics of their overall composition or disease-induced alterations. Methods: In this retrospective study, a total of 35 ICF samples (49% mucinous) obtained via EUS-FNA (fine needle aspiration) were analyzed using TLB. Thermogram data were utilized to develop predictive models for differential diagnosis between mucinous and non-mucinous PCLs or malignancy detection through machine learning algorithms. Results: Two classification models were developed: TLB1 (“mucinous” vs. “non-mucinous” PCLs) and TLB2 (“benign mucinous” vs. “malignant mucinous” PCLs). The TLB1 model demonstrated a sensitivity of 92% and a negative predictive value of 86%, with an area under the curve (AUC) of 0.79 (0.59–0.99), indicating good discriminative ability between the two groups. The TLB2 model exhibited excellent predictive capability, with an AUC of 1.00. Conclusions: TLB analysis of PCLs is a promising tool that could significantly enhance the differential diagnosis of PCLs, enabling the efficient identification of mucinous lesions and even those undergoing malignant transformation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Identification of new ClpC1-NTD binders for Mycobacterium tuberculosis drug development

  • Weinhäupl, Katharina
  • Meuret, Louis
  • Desrat, Sandy
  • Roussy, Fanny
  • Morellet, Nelly
  • Beaupierre, Sandra
  • Guillou, Catherine
  • van Heijenoort, Carine
  • Abian, Olga
  • Vega, Sonia
  • Wolf, Ian
  • Akopian, Tatos
  • Krandor, Olga
  • Rubin, Eric
  • Velazquez-Campoy, Adrian
  • Gauto, Diego
  • Fraga, Hugo
MtbClpC1 is a promising drug target against tuberculosis. Recent studies have shown that several natural product antibiotics targeting the unfoldase N-terminal domain can impair MtbClpC1 function resulting in cell death. While the pharmacological properties of these natural product antibiotics prevent their use in the clinic, similar molecules binding to the same binding pockets can result in new drugs against Mtb. Here we demonstrate that we successfully used in silico screening to identify new ClpC1 N-terminal domain binders with micromolar affinity from a small compound library. In addition, we experimentally demonstrate that the new compounds bind to the same pockets used by the natural product antibiotics and inhibit ClpC1 function.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Serum-Based Detection of Pancreatic and Ovarian Cancer via a Nanoparticle-Enhanced Fluorescence Array and Machine Learning

  • Morcuende-Ventura, Violeta
  • Sánchez-Gracia, Oscar
  • Abian-Franco, Natalia
  • Jiménez-Pardo, Isabel
  • Herrer, Lucía
  • Castillo-Vallés, Martín
  • Lancelot, Alexandre
  • Falcó-Martí, F. Javier
  • Hermoso-Durán, Sonia
  • Pazo-Cid, Roberto
  • Lanas, Ángel
  • Velazquez-Campoy, Adrián
  • Sierra, Teresa
  • Abian, Olga
Early detection of oncological diseases such as pancreatic ductal adenocarcinoma (PDAC) and ovarian cancer (OV) is pivotal for successful treatment but remains a significant challenge due to the lack of sensitive and specific diagnostic tests. Fluorescence spectroscopy, enhanced by the interaction of serum proteins with nanoparticles (NPs) based on linear–dendritic block copolymers, has emerged as a promising technique for the noninvasive detection of these malignancies. This study introduces a novel array-based assay methodology to evaluate the diagnostic capabilities of various NPs within serum samples using fluorescence. Methods: We synthesized three types of NPs (1-SH, 2-OH, 3-NH3+) and analyzed their fluorescence spectra in serum samples from patients with PDAC, OV, and control subjects. The samples were excited at 330 and 350 nm wavelengths to obtain their fluorescence emission spectra. An array of machine learning algorithms was applied, including boosting and tree-based methods, to assess the ability of the spectral data to discriminate between pathological and nonpathological states. The algorithms’ performance was measured by the area under the receiver operating characteristic curves (AUC). Results: The fluorescence spectra revealed distinct patterns for PDAC and OV pathologies. 3-NH3+ NPs exhibited the highest differential capacity with AUCs exceeding 80% for PDAC across all algorithms, except one. 2-OH NPs showed a strong discriminatory ability for OV with AUCs over 70%, utilizing all but one of the algorithms. 1-SH NPs, however, did not significantly increase differentiability. Boosting algorithms generally outperformed other methods, indicating their suitability for this diagnostic approach. Conclusions: The proposed assay array methodology enables the systematic evaluation of NPs’ diagnostic potential using fluorescence spectroscopy. The differential interactions between NPs and serum proteins specific to PDAC and OV highlight the method’s capability to discern pathological states. These findings suggest a path forward for developing NP-assisted fluorescence spectroscopy as a viable tool for cancer diagnostics, potentially leading to earlier detection and improved patient outcomes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Zinc cofactor in human histone deacetylase 8: Requirement for function and opportunity for drug discovery

  • Garcia-Franco, Paula M.
  • Falcó-Martí, F. Javier
  • Jeblaoui, Hajar
  • Asencio del Rio, Marta
  • Ortega-Alarcon, David
  • Vega, Sonia
  • Galano-Frutos, Juan J.
  • Abian, Olga
  • Velazquez-Campoy, Adrian
HDAC8 (histone deacetylase 8), a class I HDAC, is a promising target for different disorders: X-linked intellectual disability, fibrotic disease, cancer, and several neuropathological diseases. The structural and functional similarity between HDACs hinders the development of selective HDAC8 inhibitors. To date, no drugs based on competitive inhibition have been approved. In order to identify weaknesses in HDAC8 amenable to drug discovery, we report here a comprehensive thermodynamic characterization of the structural stability and its modulation by the interaction with its zinc (Zn2+) cofactor using a combination of experimental and computational techniques. HDAC8 represents an interesting example of an allosteric protein in the broad sense, in which its cofactor, the zinc ion, modulates its conformational equilibrium. The native, inactive, zinc-free state is physiologically relevant considering that the intracellular concentration of zinc is very low and may constitute a valid target for drug discovery.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Integrating thermal liquid biopsy, clinical data, and mass spectrometry for early diagnosis and biomarker discovery in colorectal cancer

  • Hermoso-Durán, Sonia
  • Ortega-Alarcón, David
  • Johansen, Astrid Z.
  • McKay, Mattew J.
  • Johansen, Julia S.
  • Vega, Sonia
  • Feltoft, Claus L.
  • Dolin, Troels Gammeltoft
  • Lykke, Jakob
  • Fraunhoffer, Nicolas
  • Sánchez-Gracia, Oscar
  • Garrido, Pablo F.
  • Lanas, Ángel
  • Molloy, Mark P.
  • Velázquez-Campoy, Adrian
  • Abian, Olga
Early detection of colorectal cancer is essential to improving survival, where yet current diagnostic tools show limited performance. This study aimed to enhance diagnostic accuracy by integrating clinical variables with thermogram profiles obtained through serum-based thermal liquid biopsy and analyzed using machine learning models. We evaluated 328 patients with colorectal cancer and 355 symptomatic individuals with non-organ-specific cancer signs but negative diagnostic evaluations, to reproduce clinically relevant decision settings. The combined model showed improved classification performance compared with the use of clinical variables alone, particularly in patients with early-stage disease. In addition, proteomic analysis of samples stratified by thermogram patterns identified proteins associated with survival, including fibrinogen-like protein 1, supporting the biological relevance of these thermodynamic profiles. Together, these findings indicate that integrating serum thermogram information with routine clinical data can modestly strengthen diagnostic assessment and help identify biologically meaningful patient subgroups, offering a promising non-invasive colorectal
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Repurposing Drugs as Bacteroides fragilis BFT-3 Inhibitors in the Animal Infection Model Galleria mellonella

  • Jiménez-Alesanco, Ana
  • Gómara-Lomero, Marta
  • Jeblaoui, Hajar
  • Vega, Sonia
  • Velázquez-Campoy, Adrián
  • Aínsa, José Antonio
  • Abián, Olga
Bacteroides fragilis is a key component of the human gut microbiota, although enterotoxigenic strains (ETBF), which produce B. fragilis toxin (BFT), can act as opportunistic pathogens. BFT disrupts intestinal epithelial integrity and contributes to conditions such as inflammatory bowel disease and colorectal cancer. This study aimed to characterize three allosteric inhibitors of BFT-3 (isoform 3 of BFT), previously identified by our group through high-throughput screening of US Food and Drug Administration approved drugs. We evaluated their activities in vitro and in vivo. Using Galleria mellonella larvae as a novel infection model for B. fragilis, we assessed the antimicrobial and antivirulence potential of these compounds. Among the three tested compounds, MOA4 demonstrated superior efficacy, enhanced bacterial clearance in vivo, and increased larval survival in a dose-dependent manner, with minimal toxicity. Synergy studies have revealed the potential combinatory effects of MOA4 and conventional antibiotics. These findings establish G. mellonella as a valuable alternative model for studying B. fragilis infections and highlight MOA4 as a promising candidate to be repurposed for the treatment of B. fragilis-mediated diseases while preserving commensal microbiota.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Extending MeCP2 interactome, canonical nucleosomal histones interact with MeCP2

  • Ortega-Alarcon, David|||0000-0003-1885-4365
  • Claveria-Gimeno, Rafael
  • Vega, Sonia
  • Kalani, Ladan|||0000-0002-0892-3745
  • Jorge-Torres, Olga Caridad|||0000-0002-1219-8865
  • Esteller, M.|||0000-0003-4490-6093
  • Ausio, Juan
  • Abián, Olga|||0000-0001-5664-1729
  • Velázquez-Campoy, Adrián|||0000-0001-5702-4538
MeCP2 is a general regulator of transcription involved in the repression/activation of genes depending on the local epigenetic context. It acts as a chromatin regulator and binds with exquisite specificity to gene promoters. The set of epigenetic marks recognized by MeCP2 has been already established (mainly, cytosine modifications in CpG and CpA), as well as many of the constituents of its interactome. We unveil a new set of interactions for MeCP2 with the four canonical nucleosomal histones. MeCP2 interacts with high affinity with H2A, H2B, H3 and H4. In addition, Rett syndrome associated mutations in MeCP2 and histone epigenetic marks modulate these interactions. Given the abundance and the structural/functional relevance of histones and their involvement in epigenetic regulation, this new set of interactions and its modulating elements provide a new addition to the 'alphabet' for this epigenetic reader.